Contraindicated: Canada can’t solve US pharmaceutical woes.
The US Congress is once again considering authorization of the re-importation of pharmaceuticals from Canada. As AIMS Fellow in Health Care Economics Brian Ferguson explains in a commentary in the National Post, such a solution to the US pharmaceutical woes is a dream cop-out for politicians.